Farmaatsiatoodete Arendus OÜRegistered
Key figures
1 586 047 €+2914,6%
Revenue 2025
+2914,6%
Average annual growth 2024–2025
Ratios
20255,9%
Profit margin
28,2%
Equity ratio
1,3×
Current ratio
94,2%
Return on equity
5776 €
Average gross salary
Balance sheet structure
Current assetsNon-current assetsLiabilitiesEquity
Quarterly figures
| Quarter | Revenue | Number of employees | Labour taxes |
|---|---|---|---|
| Q2 2026 | 425 483 € | 18 | 176 142 € |
| Q1 2026 | 433 228 € | 18 | 148 892 € |
| Q4 2025 | 410 985 € | 18 | 147 758 € |
| Q3 2025 | 416 882 € | 18 | 151 868 € |
| Q2 2025 | 286 641 € | 18 | 147 242 € |
| Q1 2025 | 247 765 € | 17 | 89 629 € |
Source: Tax Board open data — based on VAT returns, may not exactly match revenue in the annual report. Updated quarterly.
Summary of financial statements2024–2025
| 2024 | 2025 | |
|---|---|---|
| Balance sheet — assets | ||
| Total current assets | 55 111 | 338 707 |
| Total non-current assets | 10 926 | 13 595 |
| Total assets | 66 037 | 352 302 |
| Balance sheet — liabilities and equity | ||
| Current liabilities | 60 280 | 252 924 |
| Non-current liabilities | — | — |
| Total liabilities | 60 280 | 252 924 |
| Share capital | 2500 | 2500 |
| Retained earnings of previous periods | — | 3257 |
| Profit for the year | 3257 | 93 621 |
| Total equity | 5757 | 99 378 |
| Income statement | ||
| Sales revenue | 52 612 | 1 586 047 |
| Operating profit | 3325 | 94 654 |
| Profit before income tax | 3257 | 93 621 |
| Profit for the reporting year | 3257 | 93 621 |
| Labour costs | 29 783 | 1 381 293 |
| Depreciation of non-current assets | — | — |
| Other indicators | ||
| Employees | 1 | 18 |
| Calculated dividend | — | 0 |
A dash (—) means the report has not been filed or the line is not reported; 0 is a zero stated in the report.
Connections graph
CompanyPersonShareholderOther roleAdditional link
Annual reportsPDF, XBRL
Loading list of reports…
Source: e-Business Register (RIK). Files open/download directly from the official register.
Related companies
Same activity — All other professional, scientific and technical activities n.e.c.